ZORBTIVE Side Effects

6381851-3 | Angina Pectoris, Dizziness, Electrocardiogram Change, Headache, Hyperglycaemia, Joint Stiffness, Joint Swelling, Nephrolithiasis, Oedema Peripheral
on Sep 11, 2009 Male patient from UNITED STATES , 57 years of age, weighting 231.5 lb, was diagnosed with short-bowel syndrome, crohn's disease (What is crohn's disease?) and was treated with Zorbtive (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, dizziness (What is dizziness?), electrocardiogram change, headache (What is headache?), hyperglycaemia, joint stiffness, joint swelling, nephrolithiasis, oedema peripheral. Zorbtive dosage: . During the same period patient was treated with REMICADE (Intravenous; 5 Mg/kg, Intravenous; 5 Mg/kg, Intravenous; 10 Mg/kg, Intravenous) (View Remicade Review and Remicade Label ), VITAMIN B12 (View Vitamin B12 Review and Vitamin B12 Label ), ADALIMUMAB (ADALIMUMAB) (View Adalimumab (adalimumab) Review and Adalimumab (adalimumab) Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

5842712-9 | Catheter Related Infection, Nausea, Pyrexia, White Blood Cell Count Decreased
Patient was taking Zorbtive (View Usage). Patient had the following side effects: catheter related infection, nausea (What is nausea?), pyrexia, white blood cell count decreased on Jul 29, 2008 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 168.0 lb, was diagnosed with short-bowel syndrome and. Zorbtive dosage: 7 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), GLUTAMINE (LEVOGLUTAMIDE) (View Glutamine (levoglutamide) Review and Glutamine (levoglutamide) Label ), PREVACID (View Prevacid Review and Prevacid Label ), SCOPOLAMINE (HYOSCINE/ 00008701/) (View Scopolamine (hyoscine/ 00008701/) Review and Scopolamine (hyoscine/ 00008701/) Label ). Patient was hospitalized.

5689862-8 | Bacteraemia, Diarrhoea, Nephrolithiasis
Adverse event was reported on Mar 31, 2008 by a Female patient taking Zorbtive (View Usage) (Dosage: 6.0mg Qd Subcutaneous) was diagnosed with gastrointestinal disorder and. Location: UNITED STATES , 54 years of age, weighting 129.2 lb, After Zorbtive was administered, patient had the following side effects: bacteraemia, diarrhoea, nephrolithiasis. During the same period patient was treated with TPN (View Tpn Review and Tpn Label ), COREG (View Coreg Review and Coreg Label ), ZOCOR (View Zocor Review and Zocor Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ), PREVACID (View Prevacid Review and Prevacid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

5542777-8 | Clostridial Infection
on Nov 27, 2007 Female patient from UNITED STATES , 75 years of age, was diagnosed with off label use and was treated with Zorbtive (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection. Zorbtive dosage: . Patient was hospitalized.


5534241-7 | Back Pain, Bacteraemia, Headache, International Normalised Ratio Decreased, International Normalised Ratio Increased
on Dec 05, 2007 Female patient from UNITED STATES , 33 years of age, weighting 197.9 lb, was diagnosed with short-bowel syndrome and was treated with Zorbtive (View Usage). Patient had the following side effects: back pain (What is back pain?), bacteraemia, headache (What is headache?), international normalised ratio decreased, international normalised ratio increased. Zorbtive dosage: 8.0mg Qd Subcutaneous. During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LANTUS (View Lantus Review and Lantus Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), OPIUM (View Opium Review and Opium Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ). Patient was hospitalized.

5481123-5 | Arthralgia, Blood Testosterone Decreased, Blood Testosterone Free Decreased, Blood Thyroid Stimulating Hormone Decreased, Breast Engorgement, Breast Tenderness, Chest Pain, Clostridial Infection, Diarrhoea
Patient was taking Zorbtive (View Usage). After Zorbtive was administered, patient had the following side effects: arthralgia, blood testosterone decreased, blood testosterone free decreased, blood thyroid stimulating hormone decreased, breast engorgement, breast tenderness, chest pain (What is chest pain?), clostridial infection, diarrhoea on Sep 24, 2007 from UNITED STATES Additional patient health information: Male patient , 41 years of age, weighting 157.0 lb, was diagnosed with short-bowel syndrome and. Zorbtive dosage: 8.4 Mg, 1 In 1 Days, Subcutaneous; 6.5 Mg, 1 In 1 Days, Subcutaneous. During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ), HUMIRA (View Humira Review and Humira Label ). Patient was hospitalized.

5385026-6 | Blood Alkaline Phosphatase Increased, Nausea, Pancreatitis Acute, Troponin Increased
Adverse event was reported on Jul 06, 2007 by a Female patient taking Zorbtive (View Usage) (Dosage: 6.0 Mg Qd Sq) was diagnosed with short-bowel syndrome and. Location: UNITED STATES , weighting 131.4 lb, Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, nausea (What is nausea?), pancreatitis acute, troponin increased. During the same period patient was treated with CATAPRES (View Catapres Review and Catapres Label ), REGLAN (View Reglan Review and Reglan Label ). Patient was hospitalized.